...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice
【24h】

Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice

机译:促红细胞生成素介导的肝素抑制小鼠所需的Smad1 / 5

获取原文
获取原文并翻译 | 示例

摘要

Anemia suppresses liver hepcidin expression to supply adequate iron for erythropoiesis. Erythroferrone mediates hepcidin suppression by anemia, but its mechanism of action remains uncertain. The bone morphogenetic protein (BMP)-SMAD signaling pathway has a central role in hepcidin transcriptional regulation. Here, we explored the contribution of individual receptor-activated SMADs in hepcidin regulation and their involvement in erythroferrone suppression of hepcidin. In Hep3B cells, SMAD5 or SMAD1 but not SMAD8, knockdown inhibited hepcidin (HAMP) messenger RNA (mRNA) expression. Hepatocyte-specific double-knockout Smad1(fl/fl); Smad5(fl/fl); Cre(+) mice exhibited similar to 90% transferrin saturation and massive liver iron overload, whereas Smad1(fl/fl); Smad5(fl/wt); Cre(+) mice or Smad1(fl/wt); Smad5(fl/fl); Cre(+) female mice with 1 functional Smad5 or Smad1 allele had modestly increased serum and liver iron, and single-knockout Smad5(fl/fl); Cre(+) or Smad1(fl/fl); Cre(+) mice had minimal to no iron loading, suggesting a gene dosage effect. Hamp mRNA was reduced in all Cre(+) mouse livers at 12 days and in all Cre(+) primary hepatocytes. However, only double-knockout mice continued to exhibit low liver Hamp at 8 weeks and failed to induce Hamp in response to Bmp6 in primary hepatocyte cultures. Epoetin alfa (EPO) robustly induced bone marrow erythroferrone (Fam132b) mRNA in control and Smad1(fl/fl); Smad5(fl/fl); Cre(+) mice but suppressed hepcidin only in control mice. Likewise, erythroferrone failed to decrease Hamp mRNA in Smad1(fl/fl); Smad5(fl/fl); Cre(+) primary hepatocytes and SMAD1/SMAD5 knockdown Hep3B cells. EPO and erythroferrone reduced liver Smad1/5 phosphorylation in parallel with Hamp mRNA in control mice and Hep3B cells. Thus, Smad1 and Smad5 have overlapping functions to govern hepcidin transcription. Moreover, erythropoietin and erythroferrone target Smad1/5 signaling and require Smad1/5 to suppress hepcidin expression.
机译:贫血抑制肝肝素的表达,为促红细胞产生足够的铁。 erythroferrone通过贫血培养肝素抑制,但其行动机制仍然不确定。骨形态发生蛋白(BMP)-Smad信号通路在肝素转录调节中具有重要作用。在这里,我们探讨了肝素调节中个体受体激活的Smads的贡献及其参与Hepcidin的erythroferrone抑制。在HEP3B细胞中,Smad5或Smad1但不smad8,敲低抑制肝素(HAMP)信使RNA(mRNA)表达。特定肝细胞的双敲除Smad1(FL / FL); Smad5(FL / FL); CRE(+)小鼠表现出类似于90%的转铁蛋白饱和度和大量肝脏铁过载,而Smad1(FL / FL); Smad5(FL / WT); CRE(+)小鼠或SMAD1(FL / WT); Smad5(FL / FL); CRE(+)雌性小鼠用1个功能性SMAD5或SMAD1等位基因具有适度增加的血清和肝脏铁,并单敲除SMAD5(FL / FL); CRE(+)或SMAD1(FL / FL); CRE(+)小鼠没有铁载荷最小,表明基因剂量效应。在12天和所有CRE(+)原发性肝细胞中,在所有CRE(+)小鼠肝脏中,在所有CRE(+)小鼠肝脏中减少了HAMP mRNA。然而,只有双敲除小鼠在8周内继续表现出低肝恒生,并且在原发性肝细胞培养物中没有响应BMP6而未诱导恒生。 Epoetin Alfa(EPO)强大地诱导控制和Smad1(FL / FL)的骨髓红甲酮(FAM132B)mRNA; Smad5(FL / FL); CRE(+)小鼠,但仅在对照小鼠中抑制肝素。同样,红葡萄酒未能减少SMAD1(FL / FL)中的跃迁mRNA; Smad5(FL / FL); CRE(+)原发性肝细胞和SMAD1 / SMAD5敲低HEP3B细胞。 EPO和Erythroferrone在对照小鼠和Hep3b细胞中与肝脏mRNA平行降低肝脏Smad1 / 5磷酸化。因此,Smad1和Smad5具有重叠的功能来治理肝蛋白转录。此外,促红细胞生成素和erythroferrone靶Smad1 / 5信号传导,需要Smad1 / 5来抑制肝素的表达。

著录项

  • 来源
  • 作者单位

    Harvard Med Sch Massachusetts Gen Hosp Div Nephrol Program Anemia Signaling Res Boston MA USA;

    Harvard Med Sch Massachusetts Gen Hosp Div Nephrol Program Anemia Signaling Res Boston MA USA;

    Harvard Med Sch Massachusetts Gen Hosp Div Nephrol Program Anemia Signaling Res Boston MA USA;

    Harvard Med Sch Massachusetts Gen Hosp Div Nephrol Program Anemia Signaling Res Boston MA USA;

    Harvard Med Sch Massachusetts Gen Hosp Shriners Hosp Children Ctr Engn Med Dept Surg Boston MA;

    Katholieke Univ Leuven VIB Ctr Biol Dis Lab Dev Signaling Leuven Belgium;

    Katholieke Univ Leuven VIB Ctr Biol Dis Lab Dev Signaling Leuven Belgium;

    Harvard Med Sch Massachusetts Gen Hosp Div Nephrol Program Anemia Signaling Res Boston MA USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 血液及淋巴系疾病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号